{
    "paper_id": "e0c0b8b911613511a56c06d11185a55de24eb829",
    "metadata": {
        "title": "Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease",
        "authors": [
            {
                "first": "Lang",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Chemical synthesis of \u03c9-azido-sphingosine",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Commercially available chemical reagents, purchased from Sigma-Aldrich, Alfa Aesar, TCI and ACROS, were used as received without further purification. All solvents were distilled before usage and moisture-sensitive reactions were performed under nitrogen atmosphere. Analytical thin-layer chromatography (TLC) was performed using silica gel coated aluminum plates with a thickness of 0.2 mm (Macherey-Nagel). The compounds were visualized with a potassium permanganate stain solution containing 1.50 g KMnO 4 , 10.0 g K 2 CO 3 and 100 mg NaOH in 200 mL H 2 O. Liquid column chromatography purification was performed with silica gel 60 (40-63 \u03bcm mesh, Macherey-Nagel). Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance III HD 400 at 295 K. Chemical shifts (\u03b4) are given in parts per million (ppm) with respect to the solvent residual proton signals (\u03b4(CDCl 3 ) = 7.26 ppm, \u03b4(CD 3 OD) = 3.31 ppm) for 1 H or the resonance signals (\u03b4(CDCl 3 ) = 77.16 ppm, \u03b4(CD 3 OD) = 49.00 ppm) for 13 C. Coupling constants (J) are reported in Hertz (Hz) and the multiplicity is abbreviated as s (singlet), d (doublet), t (triplet), m (multiplet), dd (doublet of doublets), br d (broad doublet) etc. Signal assignment was performed with additional information of DEPT135, ( 1 H, 1 H)-COSY, ( 1 H, 13 C)-HSQC and ( 1 H, 13 C)-HMBC. Atom numbers do not refer to the IUPAC nomenclature. High resolution mass spectrometry (HRMS) was performed with a Bruker Daltonics micrOTOF-Q III (electrospray ionization, ESI) instrument.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Synthesis route of \u03c9-azido-sphingosine: The sphingoid backbone was obtained by olefin cross-metathesis reaction using Grubbs catalyst 2 nd generation, which is a known method for the synthesis of various sphingolipid derivatives 1,2 . An azide-tagged sphingosine analogue with a C 14 -backbone has already been described by Garrido et al. in 2015 3 . Here we synthesized a more natural C 18 long-chain base, starting from the building blocks tert-butyl ((2S,3R)-1-((tert-butyldimethylsilyl)oxy)-3-hydroxypent-4-en-2-yl)carbamate (1) and 15bromopentadec-1-ene (2). The syntheses of the allylic alcohol (1) and the brominated alkene (2) were performed according to literature 1,2 . After metathesis reaction, the desired E-configurated alkene tert-butyl ((2S,3R,E)-18-bromo-1-((tertbutyldimethylsilyl)oxy)-3-hydroxyoctadec-4-en-2-yl)carbamate (3) was isolated in 50% yield by column chromatography. Nucleophilic substitution of the terminal bromide with sodium azide in N,N-dimethylformamide afforded tert-butyl ((2S,3R,E)-18-azido-1-((tert-butyldimethylsilyl)oxy)-3-hydroxyoctadec-4-en-2-yl)carbamate (4) in an excellent yield. Subsequent cleavage of the silyl ether using tetra-n-butylammonium fluoride in tetrahydrofuran gave diol tert-butyl ((2S,3R,E)-18-azido-1,3dihydroxyoctadec-4-en-2-yl)carbamate (5) in quantitative yield. In the final step, a dichloromethane solution of the carbamate was treated with trifluoroacetic acid to provide \u03c9-azido-sphingosine (6) in 61% yield. All isolated compounds were fully characterized by a combination of 1 H-and 13 C-NMR spectroscopy and HRMS. 50 GO_ENDOCYTIC_VESICLE 223 0,34582347 1,6779151 0,041357946 0,499 3881 tags=33%, list=16%, signal=39% 3 GO_EARLY_ENDOSOME 262 0,4225165 2,0901139 0,009000001 0,009 4259 tags=40%, list=18%, signal=48% 5 GO_EARLY_ENDOSOME_MEMBRANE 90 0,45907736 2,0442317 0,017993936 0,048 4368 tags=44%, list=18%, signal=54% 40 GO_RETROMER_COMPLEX 19 0,70777726 1,7091843 0,037392348 0,419 4075 tags=68%, list=17%, signal=82% 4 GO_LATE_ENDOSOME_MEMBRANE 87 0,49950457 2,0850801 0,009 0,009 4528 tags=52%, list=19%, signal=63% 7 GO_LATE_ENDOSOME 184 0,44429532 2,0017903 0,020909633 0,085 4704 tags=44%, list=19%, signal=54% 8 GO_ENDOSOMAL_PART 370 0,42579743 1,9757125 0,023100177 0,085 4576 tags=44%, list=19%, signal=53% 33 GO_RECYCLING_ENDOSOME 118 0,40409502 1,7256137 0,0396777 0,381 4368 tags=41%, list=18%, signal=49% 9 GO_LYTIC_VACUOLE 463 0,4277387 1,9631885 0,021533486 0,085 4530 tags=44%, list=19%, signal=53% 12 GO_LYTIC_VACUOLE_MEMBRANE 235 0,48414743 1,9161127 0,025993459 0,14 4362 tags=49%, list=18%, signal=59% 26 GO_VACUOLAR_LUMEN 104 0,3773395 1,7634717 0,0366276 0,319 3524 tags=38%, list=15%, signal=45% 27 GO_BLOC_COMPLEX 17 0,6160383 1,7550533 0,03736286 0,319 3791 tags=59%, list=16%, signal=70% 38 GO_LYSOSOMAL_LUMEN 81 0,38517004 1,7134563 0,037687793 0,401 3471 tags=41%, list=14%, signal=47% 18 GO_REPLICATION_FORK 58 0,5975565 1,8338519 0,031645566 0,223 6436 tags=71%, list=26%, signal=96% 39 GO_MIDBODY 116 0,35698095 1,7105753 0,03786879 0,419 5584 tags=46%, list=23%, signal=59% 41 GO_REPLISOME 28 0,6371837 1,7077754 0,036902785 0,419 6765 tags=75%, list=28%, signal=104% 42 GO_NUCLEAR_REPLICATION_FORK 38 0,57244664 1,7048541 0,03673616 0,429 6436 tags=68%, list=26%, signal=93% 54 GO_SPINDLE 252 0,3613654 1,653535 0,048039164 0,579 5675 tags=42%, list=23%, signal=54% 28 GO_CHROMOSOME_CENTROMERIC_REGION 158 0,44841677 1,7494394 0,03919173 0,35 5584 tags=46%, list=23%, signal=59% 52 GO_CHROMOSOMAL_REGION 295 0,39017215 1,6661352 0,04389605 0,553 6047 tags=44%, list=25%, signal=58% 14 GO_CENTRIOLE 86 0,45790482 1,8774872 0,027173832 0,153 4879 tags=43%, list=20%, signal=54% 45 GO_MICROTUBULE_ORGANIZING_CENTER_PART 123 0,42793038 1,6979736 0,03635697 0,429 5643 tags=46%, list=23%, signal=60% 11 GO_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN 16 0,67587835 1,9239477 0,026597569 0,13 4100 tags=56%, list=17%, signal=68% 13 GO_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX 22 0,6414163 1,8885471 0,027705144 0,14 4100 tags=64%, list=17%, signal=76% 17 GO_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX 42 0,58050895 1,8385583 0,030986838 0,206 4100 tags=52%, list=17%, signal=63% 22 GO_ORGANELLE_INNER_MEMBRANE 485 0,3901529 1,7873535 0,036679573 0,278 5738 tags=40%, list=24%, signal=51% 29 GO_ORGANELLAR_RIBOSOME 70 0,48045403 1,7429737 0,038928393 0,35 5017 tags=47%, list=21%, signal=59% 31 GO_MITOCHONDRIAL_MEMBRANE_PART 154 0,4452351 1,7304742 0,040072706 0,37 6149 tags=45%, list=25%, signal=60% 32 GO_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX 93 0,4993963 1,7265102 0,040178046 0,37 5710 tags=46%, list=24%, signal=60% 35 GO_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE 237 0,32457468 1,7241015 0,038970415 0,381 4674 tags=33%, list=19%, signal=41% 43 GO_MITOCHONDRIAL_MATRIX 389 0,34331876 1,7011355 0,036091138 0,429 5166 tags=36%, list=21%, signal=45% 47 GO_MITOCHONDRIAL_PROTEIN_COMPLEX 123 0,44945076 1,6955893 0,03665585 0,475 6139 tags=46%, list=25%, signal=61% 49 GO_RESPIRATORY_CHAIN 75 0,49076676 1,6788516 0,0411818 0,499 5710 tags=43%, list=24%, signal=56% 51 GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE 44 0,46190116 1,6689262 0,04424508 0,535 4932 tags=43%, list=20%, signal=54% 53 GO_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE 17 0,5082864 1,6564015 0,047987744 0,561 2770 tags=41%, list=11%, signal=46% 10 GO_AXON_CYTOPLASM 31 0,50222677 1,9246219 0,028357327 0,13 3791 tags=42%, list=16%, signal=50% 21 GO_IMMUNOLOGICAL_SYNAPSE 32 0,54109186 1,7903459 0,037997648 0,278 4488 tags=47%, list=18%, signal=57% 23 GO_TRANS_GOLGI_NETWORK_MEMBRANE 64 0,49522012 1,7766278 0,037670236 0,305 3780 tags=44%, list=16%, signal=52% 24 GO_MICROBODY 129 0,3392097 1,7741073 0,036906812 0,305 5560 tags=37%, list=23%, signal=48% 25 GO_PIGMENT_GRANULE 99 0,41682222 1,7652943 0,0377327 0,319 3780 tags=34%, list=16%, signal=41% 36 GO_AUTOPHAGOSOME 68 0,3550243 1,7179679 0,039000235 0,388 4494 tags=43%, list=19%, signal=52% 44 GO_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE 22 0,46452084 1,6993158 0,035895374 0,429 5634 tags=50%, list=23%, signal=65% 48 GO_PML_BODY 87 0,46760246 1,6898024 0,037775308 0,483 5943 tags=45%, list=24%, signal=59% 55 GO_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE 95 0,33212984 1,6519495 0,04801346 0,579 2920 tags=26%, list=12%, signal=30%",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "To a solution of allylic alcohol 1 (2.00 g, 6.03 mmol, 1.00 eq.) and alkene 2 (6.98 g, 24.1 mmol, 4.00 eq.) in dry CH 2 Cl 2 (50 mL) was added Grubbs catalyst 2 nd generation (154 mg, 181 \u03bcmol, 0.03 eq.) at rt. The reaction mixture was stirred at 50\u00b0C for 2 h. The solvent was removed under reduced pressure and the residue was purified by column chromatography on silica gel (CyH:EtOAc, 1:0 to 9:1 v/v) to give 3 (1.80 g, 3 .03 mmol, 50 %) as a colourless, waxy solid. Chemical synthesis of \u03c9-azido-sphingosine tert-Butyl ((2S,3R,E)-18-azido-1-((tert-butyldimethylsilyl)oxy)-3-hydroxyoctadec-4-en-2-yl)carbamate (4) To a solution of bromide 3 (1.00 g, 1.69 mmol, 1.00 eq.) in DMF (20 mL) was added NaN 3 (329 mg, 5.06 mmol, 3.00 eq.). The reaction mixture was stirred at 70\u00b0C for 18 h, cooled to rt and then H 2 O (100 mL) was added. After the extraction with EtOAc (5 x 30 mL), the combined organic phases were washed with brine (20 mL) and dried (MgSO 4 Chemical synthesis of \u03c9-azido-sphingosine tert-Butyl ((2S,3R,E)-18-azido-1,3-dihydroxyoctadec-4-en-2-yl)carbamate (5) To a solution of silyl ether 4 (1.84 g, 3.32 mmol, 1.00 eq.) in dry THF (35 mL) was added TBAF (1 M in THF, 3.98 mL, 3.98 mmoL, 1.20 eq.) at 0\u00b0C. The ice bath was removed and the reaction mixture was stirred at rt for 30 min. After the addition of H 2 O (50 mL) and brine (50 mL), the aqueous layer was extracted with EtOAc (5 x 50 mL). The combined organic phases were washed with brine (25 mL), dried (MgSO 4 ) and the solvents were removed under reduced pressure. The residue was purified by column chromatography on silica gel (CyH:EtOAc, 2:1 v/v) to give 5 (1.46 g, 3.31 mmol, quant.) as a colourless, waxy solid. Chemical synthesis of \u03c9-azido-sphingosine (2S,3R,E)-2-Amino-18-azidooctadec-4-ene-1,3-diol / \u03c9-azido-sphingosine (6) To a solution of carbamate 5 (900 mg, 2.04 mmol) in CH 2 Cl 2 (20 mL) was added TFA (4.72 mL) at 0\u00b0C. The reaction mixture was stirred at 0\u00b0C for 2 h and subsequently treated with H 2 O (100 mL) and 1 M aq. NaOH (100 mL). After the extraction with EtOAc (10 x 50 mL), the combined organic phases were washed with brine (10 mL), dried (MgSO 4 ) and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel (CH 2 Cl 2 :MeOH, 9:1 v/v) to give 6 (423 mg, 1.24 mmol, 61 %) as a colourless, waxy solid. Ifn a r -/ -, H S V -1 ",
            "cite_spans": [
                {
                    "start": 423,
                    "end": 424,
                    "text": "3",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 949,
                    "end": 956,
                    "text": "(MgSO 4",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "tert-Butyl ((2S,3R,E)-18-bromo-1-((tert-butyldimethylsilyl)oxy)-3-hydroxyoctadec-4en-2-yl)carbamate (3)"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Versatile synthetic method for sphingolipids and functionalized sphingosine derivatives via olefin cross metathesis",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yamamoto",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hasegawa",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hakogi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Katsumura",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Org Lett",
            "volume": "8",
            "issn": "",
            "pages": "5569--5572",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Qu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ploessl",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Truong",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Kung",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "F"
                    ],
                    "last": "Kung",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Bioorg Med Chem Lett",
            "volume": "19",
            "issn": "",
            "pages": "3382--3385",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Azide-tagged sphingolipids: new tools for metabolic flux analysis",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Garrido",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Abad",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fabrias",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Casas",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Delgado",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Chembiochem",
            "volume": "16",
            "issn": "",
            "pages": "641--650",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "TLC (CyH:EtOAc, 9:1 v/v): R f = 0.25; 1 H NMR (400 MHz, CDCl 3 ): \u03b4 5.74 (dtd, 3 J 5,4 = 15.4 Hz, 3 J 5,6 = 6.8 Hz, 4 J 5,3 = 1.3 Hz, 1H, H-5), 5.49 (ddt, 3 J 4,5 = 15.4 Hz, 3 J 4,3 = 5.9 Hz, 4 J 4,6 = 1.3 Hz, 1H, H-4), 5.23 (br d, 3 J NH,2 = 8.2 Hz, 1H, NH), 4.16-4.20 (m, 1H, H-3), 3.93 (dd, 2 J 1,1 = 10.3 Hz, 3 J 1,2 = 3.0 Hz, 1H, H-1), 3.74 (br dd, 2 J 1,1 = 10.3 Hz, 3 J 1,2 = 2.6 Hz, 1H, H-1), 3.54-3.58 (m, 1H, H-2), 3.40 (t, 3 J 18,17 = 6.9 Hz, 2H, H-18), 3.33 (br d, 3 J OH,3 = 7.5 Hz, 1H, OH), 2.02-2.07 (m, 2H, H-6), 1.81-1.88 (m, 2H, H-17), 1.44 (s, 9H, H-3'), 1.25-1.42 (m, 20H, H-7-16), 0.89 (s, 9H, H-3''), 0.06 (s, 3H, H-1''), 0.06 (s, 3H, H-1''); 13 C NMR (100 MHz, CDCl 3 ): \u03b4 155.9 (C-1'), 133.2 (C-5), 129.6 (C-4), 79.5 (C-2'), 74.8 (C-3), 63.6 (C-1), 54.6 (C-2), 34.2 (C-18), 33.0 (C-17), 32.4 (C-6), 29.8, 29.7, 29.7, 29.6, 29.6, 29.3, 28.9, 28.3 (overall 10C, C-7-16), 28.5 (3C, C-3'), 25.9 (3C, C-3''), 18.2 (C-2''), \u22125.5 (C-1''), \u22125.5 (C-1''); HRMS (m/z): [M+Na] + calcd. for C 29 H 58 BrNNaO 4 Si, 614.3211; found, 614.3223.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "3 Hz, 3 J 1,2 = 3.0 Hz, 1H, H-1), 3.74 (br dd, 2 J 1,1 = 10.3 Hz, 3 J 1,2 = 2.5 Hz, 1H, H-1), 3.54-3.57 (m, 1H, H-2), 3.33 (br s, 1H, OH), 3.24 (t, 3 J 18,17 = 7.0 Hz, 2H, H-18), 2.01-2.07 (m, 2H, H-6), 1.55-1.62 (m, 2H, H-17), 1.44 (s, 9H, H-3'), 1.25-1.38 (m, 20H, H-7-16), 0.89 (s, 9H, H-3''), 0.06 (s, 3H, H-1''), 0.05 (s, 3H, H-1''); 13 C NMR (100 MHz, CDCl 3 ): \u03b4 155.9 (C-1'), 133.2 (C-5), 129.6 (C-4), 79.5 (C-2'), 74.8 (C-3), 63.6 (C-1), 54.6 (C-2), 51.6 (C-18), 32.4 (C-6), 29.8, 29.7, 29.7, 29.6, 29.6, 29.3, 29.3, 26.8 (overall 10C, C-7-16), 29.0 (C-17), 28.5 (3C, C-3'), 25.9 (3C, C-3''), 18.2 (C-2''), \u22125.5 (C-1''), \u22125.5 (C-1''); HRMS (m/z): [M+Na] + calcd. for C 29 H 58 N 4 NaO 4 Si, 577.4120; found, 577.4126.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "TLC (CyH:EtOAc, 2:1 v/v): R f = 0.20; 1 H NMR (400 MHz, CDCl 3 ): \u03b4 5.75 (dtd, 3 J 5,4 = 15.3 Hz, 3 J 5,6 = 6.8 Hz, 4 J 5,3 = 1.2 Hz, 1H, H-5), 5.50 (ddt, 3 J 4,5 = 15.3 Hz, 3 J 4,3 = 6.4 Hz, 4 J 4,6 = 1.2 Hz, 1H, H-4), 5.34 (br d, 3 J NH,2 = 7.9 Hz, 1H, NH), 4.27-4.29 (m, 1H, H-3), 3.91 (dd, 2 J 1,1 = 11.3 Hz, 3 J 1,2 = 3.7 Hz, 1H, H-1), 3.68 (dd, 2 J 1,1 = 11.3 Hz, 3 J 1,2 = 3.6 Hz, 1H, H-1), 3.56-3.59 (m, 1H, H-2), 3.24 (t, 3 J 18,17 = 7.0 Hz, 2H, H-18), 3.00 (br s, 2H, 2 x OH), 2.01-2.06 (m, 2H, H-6), 1.54-1.62 (m, 2H, H-17), 1.43 (s, 9H, H-3'), 1.24-1.38 (m, 20H, H-7-16); 13 C NMR (100 MHz, CDCl 3 ): \u03b4 156.4 (C-1'), 134.2 (C-5), 129.0 (C-4), 79.9 (C-2'), 74.8 (C-3), 62.7 (C-1), 55.5 (C-2), 51.6 (C-18), 32.4 (C-6), 29.7, 29.7, 29.7, 29.6, 29.6, 29.3, 29.3, 29.2, 26.8 (overall 10C, C-7-16), 28.9 (C-17), 28.5 (3C, C-3'); HRMS (m/z): [M+Na] + calcd. for C 23 H 44 N 4 NaO 4 , 463.3255; found, 463.3250.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": ", 1H, H-4), 4.02-4.06 (m, 1H, H-3), 3.70 (dd, 2 J 1,1 = 11.0 Hz, 3 J 1,2 = 4.4 Hz, 1H, H-1), 3.53 (dd, 2 J 1,1 = 11.0 Hz, 3 J 1,2 = 7.3 Hz, 1H, H-1), 3.28 (t, 3 J 18,17 = 6.9 Hz, 2H, H-18), 2.85 (ddd, 3 J 2,1 = 7.3 Hz, 3 J 2,3 = 5.8 Hz, 3 J 2,1 = 4.4 Hz, 1H, H-2), 2.06-2.11 (m, 2H, H-6), 1.55-1.62 (m, 2H, H-17), 1.30-1.44 (m, 20H, H-7-16); 13 C NMR (10C, C-7-16), 29.9 (C-17); HRMS (m/z): [M+H] + calcd. for C 18 H 37 N 4 O 2 , 341.2911; found, 341.2917. Efficiency of macrophage depletion by clodronate a&b:Immunofluorescence of livers (a) and spleens (b) from wild-type (WT) mice that were pretreated with control-liposomes and WT mice that were pretreated with clodronate-liposomes (day -3), infected with 6\u00d710 6 tissue culture infection dose 50 (TCID 50 ) HSV-1 and analyzed after 24 h (n = 3, blue represents Hoechst staining, scale bar 100 \u00b5m). c: Immunofluorescence of livers from WT mice that were pretreated with clodronateliposomes (day -3), infected with 8\u00d710 7 TCID 50 HSV-1 and analyzed after 1 h (n = 3, blue represents Hoechst staining, scale bar 100 \u00b5m).SupplementaryFigure 2: Herpes simplex virus type 1 (HSV-1)infection of primary fibroblastsRepresentative electron microscopy images of wild-type (WT) fibroblasts infected with HSV-1 (MOI 250) analyzed after 30 minutes (n = 106 images from three independent experiments, scale bar 5 \u00b5m). Detail shows HSV-1 close to the nucleus. Real-time polymerase chain reaction (RT-PCR) for herpes simplex virus type 1 (HSV-1) in mice with different innate immune deficiencies RT-PCR of lymph nodes (LN), spleens and livers from wild-type (WT; n = 9), Samhd1 -/-(n = 4), Ifnar1 -/-(n = 4), and MyD88 -/x Trif -/x Cardif -/-(n = 3) mice that were infected with 2\u00d710 6 tissue culture infection dose 50 (TCID 50 ) HSV-1 and analyzed on day 3 (2way Anova [Tukey's multiple comparison]). All data are shown as mean +/-SEM.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Mass spectrometric analysis and immunofluorescence microscopy of sphingolipids after treatments in different cell lines a: Mass spectrometric analysis of sphingolipids in Raw264.7 cells (n = 6-12) and bone marrow derived macrophages (BMDMs; n = 4) that were incubated for 30 minutes with 250 \u00b5M D-erythro-sphingosine (Sph), 100 \u00b5M of sphingosine kinase inhibitor (SKI), 250 U/L ceramidase (CDase) or 6.5 U/ml sphingomyelinase (SMase) and analyzed after 24 h (Raw264.7 cells, one-way Anova [Dunnett's /Kruskal-Wallis multiple comparison]) or 6h (BMDMs, one-way Anova [Dunnett's multiple comparison]). (b) BMDMs were treated for 30 minutes with 0.3 \u00b5g ceramidase, 90 minutes with 1.56 U / 250\u00b5L sphingomyelinase or left untreated (n = 3, one-way Anova [Tukey's multiple comparison]). All data are shown as mean +/-SD. * equals p \u2264 0.05, ** equals p \u2264 0.01, # equals p \u2264 0.001, ## equals p \u2264 0.0001. Supplementary Figure 4",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Expression of Asah1 in macrophages during development is dependent on IRF8 a: Real-time polymerase chain reaction (RT-PCR) results for Asah1 mRNA expression of monocytes, granulocytes and precursor cells from the myeloid lineage, isolated from wild-type (WT) and IRF8 deficient mice (n = 5-8; onetailed Student's t-test). b: Gating strategy for cell sorting. All data are shown as mean +/-SEM.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "Asah1 expression in different tissuesReal-time polymerase chain reaction (RT-PCR) for Asah1 of the indicated organs, relative to heart, derived from na\u00efve C57BL/6 mice (n = 4-5). All data are shown as mean +/-SEM. Uncropped Western blots as shown inFigure 2h.SupplementaryFigure 7",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "). The solvents were removed under reduced pressure to give 4 (930 mg, 1.68 mmol, 99 %) as a colourless, waxy solid. TLC (CyH:EtOAc, 9:1 v/v): R f = 0.25; 1 H NMR (400 MHz, CDCl 3 ): \u03b4 5.74 (dtd, 3 J 5,4 = 15.3 Hz, 3 J 5,6 = 6.8 Hz, 4 J 5,3 = 1.2 Hz, 1H, H-5), 5.49 (ddt, 3 J 4,5 = 15.3 Hz, 3 J 4,3 = 5.9 Hz, 4 J 4,6 = 1.3 Hz, 1H, H-4), 5.23 (br d, 3 J NH,2 = 8.2 Hz, 1H, NH), 4.17-4.19 (m, 1H, H-3), 3.92 (dd, 2 J 1,1 = 10.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Supplementary",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Membrane-modulating proteins in macrophages vs fibroblastsMembrane-modulating proteins from the families of sphingolipids (including gangliosides), cholesterol and phosphatidylcholine which were considered for simplified comparison of macrophages and fibroblasts.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}